Jefferies analyst Peter Welford maintains Novartis (NYSE:NVS) with a Buy and raises the price target from $121 to $122.5.
Jefferies Maintains Buy on Novartis, Raises Price Target to $122.5
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.